Hong-Ming Hu: Scaling TCR-T for solid tumors through ImmuXell's partnership with IRO®
Jul 2, 2026 - 00:45:45
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Henrik Andersen: How smart planning helps CGT scale further, faster
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Henrik Andersen, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, to explore how early planning, automation, and e...
Related Episodes
Continue listening to more episodes from Ori Spotlight.
Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 27, 2026 - 01:03:25
Joe DePinto: Why advanced therapies need a new delivery model
Jan 13, 2026 - 01:04:41
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
Dec 16, 2025 - 00:55:35
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Sep 2, 2025 - 00:40:41
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
Aug 12, 2025 - 01:00:07
